Vaccination against SARS-CoV-2 in liver transplant recipients: The game is still long and the outcome is uncertain.
作者信息
Toniutto Pierluigi, Cussigh Annarosa, Cmet Sara, Falleti Edmondo
机构信息
Hepatology and Liver Transplantation Unit, Department of Specialized Medicine, Udine University Hospital, Udine, Italy.
Clinical Pathology, Udine University Hospital, Udine, Italy.
出版信息
Liver Int. 2022 Oct;42(10):2341. doi: 10.1111/liv.15369. Epub 2022 Jul 29.
Abstract
摘要
相似文献
1
Vaccination against SARS-CoV-2 in liver transplant recipients: The game is still long and the outcome is uncertain.肝移植受者接种严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗：这场较量仍漫长，结果尚不确定。
Liver Int. 2022 Oct;42(10):2341. doi: 10.1111/liv.15369. Epub 2022 Jul 29.
2
Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients.既往 COVID-19 感染和免疫抑制方案会影响肝移植受者对 SARS-CoV-2 疫苗的长期应答。
J Hepatol. 2022 Jul;77(1):152-162. doi: 10.1016/j.jhep.2022.02.015. Epub 2022 Mar 10.
3
Sars-Cov-2 vaccination in liver transplant recipients: The 'holy grail' in a hostile environment.肝移植受者的新冠病毒疫苗接种：在不利环境中的“圣杯”。
Liver Int. 2022 Jun;42(6):1225-1228. doi: 10.1111/liv.15226.
4
Mycophenolate mofetil decreases humoral responses to three doses of SARS-CoV-2 vaccine in liver transplant recipients.霉酚酸酯降低肝移植受者对三剂 SARS-CoV-2 疫苗的体液反应。
Liver Int. 2022 Aug;42(8):1872-1878. doi: 10.1111/liv.15258. Epub 2022 Apr 2.
5
SARS-CoV-2 vaccination in liver transplant recipients: We still haven't found what we are looking for.肝移植受者接种严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗：我们仍未找到我们所寻找的答案。
Ann Hepatol. 2023 May-Jun;28(3):101081. doi: 10.1016/j.aohep.2023.101081. Epub 2023 Mar 5.
6
Humoral and Cellular Immune Response After Third and Fourth SARS-CoV-2 mRNA Vaccination in Liver Transplant Recipients.肝移植受者第三次和第四次 SARS-CoV-2 mRNA 疫苗接种后的体液和细胞免疫反应。
Clin Gastroenterol Hepatol. 2022 Nov;20(11):2558-2566.e5. doi: 10.1016/j.cgh.2022.06.028. Epub 2022 Jul 16.
7
Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient.一名肝移植受者接种基于mRNA的SARS-CoV-2疫苗后的肝损伤
Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101743. doi: 10.1016/j.clinre.2021.101743. Epub 2021 Jun 16.
8
Reduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19.COVID-19 后第一年，肝移植受者体液免疫减弱但细胞 SARS-CoV-2 特异性免疫稳定。
PLoS One. 2022 Nov 2;17(11):e0276929. doi: 10.1371/journal.pone.0276929. eCollection 2022.
9
Concurrent vaccination of kidney transplant recipients and close household cohabitants against COVID-19.肾移植受者及其密切的家庭同居者同时接种新冠疫苗。
Kidney Int. 2022 May;101(5):1077-1080. doi: 10.1016/j.kint.2022.02.015. Epub 2022 Mar 16.
10
Efficacy of anti-SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients.抗SARS-CoV-2单克隆抗体预防和疫苗接种对肾移植受者中新冠病毒奥密克戎变异株的疗效
Kidney Int. 2022 Aug;102(2):440-442. doi: 10.1016/j.kint.2022.05.007. Epub 2022 May 23.
引用本文的文献
1
Challenges in liver transplantation in the context of a major pandemic.重大疫情背景下肝移植面临的挑战。
World J Transplant. 2022 Nov 18;12(11):347-358. doi: 10.5500/wjt.v12.i11.347.
本文引用的文献
1
Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection.三剂 BNT162b2 疫苗或 BA.1 感染对奥密克戎亚谱系和德尔塔克戎 SARS-CoV-2 的中和作用。
Emerg Microbes Infect. 2022 Dec;11(1):1828-1832. doi: 10.1080/22221751.2022.2099305.
2
Association of Receipt of the Fourth BNT162b2 Dose With Omicron Infection and COVID-19 Hospitalizations Among Residents of Long-term Care Facilities.第四剂 BNT162b2 接种与长期护理机构居民感染奥密克戎和 COVID-19 住院的关联。
JAMA Intern Med. 2022 Aug 1;182(8):859-867. doi: 10.1001/jamainternmed.2022.2658.
3
Immunogenicity and safety of a third dose of anti-SARS-CoV-2 BNT16b2 vaccine in liver transplant recipients.肝移植受者接种第三剂抗 SARS-CoV-2 BNT16b2 疫苗的免疫原性和安全性。
Liver Int. 2023 Feb;43(2):452-461. doi: 10.1111/liv.15331. Epub 2022 Dec 14.
4
Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.以色列卫生保健工作者中，第三剂 BNT162b2 疫苗接种与 SARS-CoV-2 感染发生率的关联。
JAMA. 2022 Jan 25;327(4):341-349. doi: 10.1001/jama.2021.23641.
5
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.肝移植受者感染 SARS-CoV-2 后的结局：一项国际注册研究。
Lancet Gastroenterol Hepatol. 2020 Nov;5(11):1008-1016. doi: 10.1016/S2468-1253(20)30271-5. Epub 2020 Aug 28.
Zotero 插件